Michael J Sofia - Chief Scientific Officer, Arbutus Biopharma Corp

As of February 17, 2021


Michael J Sofia Net Worth

  • Net worth is estimated to be at least $5.32M
  • Owns at least 1,670,565 units of Arbutus Biopharma Corp stock
  • Sold an estimated value of $669K in the last 5 years at Arbutus Biopharma Corp

Michael J Sofia Compensation at Arbutus Biopharma Corp in 2020

  • Earned a $415,000 salary
  • Received a total compensation of $1,087,791

Michael J Sofia Trading

  • Largest sale of shares was 20,000 units , worth over $173.56K on July 10, 2018
  • In total has made about 12 transactions over 5 years
  • Usually trades in July, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Michael J Sofia Mailing Address

  • Mailing address is C/o Arbutus Biopharma Corp. Suite 100, 8900 Glenlyon Parkway Burnaby A1 V5J 5J8 British Columbia, Canada

Arbutus Biopharma Corp Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
William H. Collier 2020 $566,500 - $1,756,007 $395,842 $9,975 $2,728,324
William H. Collier 2019 $285,577 $100,000 $1,792,048 $150,945 $5,615 $2,334,185
Michael J. Sofia, Ph.D. 2020 $439,000 - $605,458 $188,770 $9,975 $1,243,203
Michael J. Sofia, Ph.D. 2019 $422,300 - $484,152 $135,136 $9,800 $1,051,388
Michael J. McElhaugh 2020 $415,000 - $484,366 $178,450 $9,975 $1,087,791
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1447028/000110465921047991/tm212510-1_def14a.htm

Arbutus Biopharma Corp Insider Trading

  • The most recent transaction was 20,000 units sold on February 10, 2021 by Michael J McElhaugh worth over $100K
  • In the last 6 years, insiders at Arbutus Biopharma Corp sold an estimated value of $1.07M and bought an estimated value of $68K
  • The most active traders are Michael J Sofia, Chief Scientific Officer,  Richard C. Henriques, Director,  and Keith Manchester, Director
  • Insider trading is most common in June, with the busiest year in 2018

Arbutus Biopharma Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1